Search details
1.
Real-World Treatment Patterns Among Patients With Metastatic Castration-Resistant Prostate Cancer: Results From an International Study.
Oncologist
; 28(9): e737-e747, 2023 09 07.
Article
in English
| MEDLINE | ID: mdl-37014097
2.
Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International Study.
Oncologist
; 28(9): 780-789, 2023 09 07.
Article
in English
| MEDLINE | ID: mdl-37014080
3.
Drivers of physician decision-making and patient perspectives across lines of therapy in multiple myeloma in the USA.
Future Oncol
; 19(22): 1549-1562, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37283044
4.
Real-world treatment patterns, healthcare resource use and disease burden in patients with multiple myeloma in Europe.
Future Oncol
; 19(31): 2103-2121, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37706245
5.
Real-world patient-reported outcomes and concordance between patient and physician reporting of side effects across lines of therapy in multiple myeloma within the USA.
Support Care Cancer
; 31(6): 371, 2023 Jun 02.
Article
in English
| MEDLINE | ID: mdl-37268868
6.
Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan.
Future Oncol
; 18(8): 937-951, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35043687
7.
Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and Japan.
BMC Urol
; 22(1): 33, 2022 Mar 11.
Article
in English
| MEDLINE | ID: mdl-35277153
8.
Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and Japan.
Adv Ther
; 39(5): 2236-2255, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35316501
9.
Qualitative and Quantitative Assessment of Patient and Carer Experience of Chemotherapy (Docetaxel) in Combination with Androgen Deprivation Therapy (ADT) for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).
Adv Ther
; 35(12): 2186-2200, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30415297
Results
1 -
9
de 9
1
Next >
>>